Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseSabatine MS, FOURIER Steering Committee and Investigators. -
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES TrialM Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators.
-
Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesWilson PWF, Polonsky TS, Miedema MD et al.
-
When high‐volume PCI operators in high‐volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes?Lu TH, Li ST, Yin WH et al.
-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failurePonikowski P, Voors AA, ESC Scientific Document Group. et al.
-
Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO RegistryJT Saxon, JA Grantham , AC Salisbury et al.
-
Chronic Total Occlusion Percutaneous Coronary Intervention: Evidence and ControversiesTajti P, Brilakis ES.
-
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)Shah B, Baber U, Mehran R et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
